LIFECORE BIOMEDICAL, INC. Temporary Equity, Accretion of Dividends
LIFECORE BIOMEDICAL, INC. (LFCR) reported Temporary Equity, Accretion of Dividends of $924.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:TemporaryEquityAccretionOfDividends · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. temporary equity, accretion of dividends for the quarter ending 2026-06-30 was $924.00K.
- LIFECORE BIOMEDICAL, INC. temporary equity, accretion of dividends for the quarter ending 2026-03-31 was $907.00K.
- LIFECORE BIOMEDICAL, INC. temporary equity, accretion of dividends for the quarter ending 2025-09-30 was $874.00K.
- LIFECORE BIOMEDICAL, INC. temporary equity, accretion of dividends for the quarter ending 2025-05-25 was $852.00K, a 7.71% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. temporary equity, accretion of dividends for fiscal 2025 was $3.32M, a 7.80% increase from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. temporary equity, accretion of dividends for fiscal 2024 was $3.08M, a 164.66% increase from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. temporary equity, accretion of dividends for fiscal 2023 was $1.16M.
| Period end | Temporary Equity, Accretion of Dividends 3 month | Temporary Equity, Accretion of Dividends 6 month | Temporary Equity, Accretion of Dividends 7 month | Temporary Equity, Accretion of Dividends 9 month | Temporary Equity, Accretion of Dividends 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $924.00K 10-Q · filed 2026-08-05 | $1.83M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $907.00K 10-Q · filed 2026-05-06 | ||||
| 2025-12-31 | $2.05M 10-KT · filed 2026-03-16 | ||||
| 2025-09-30 | $874.00K 10-Q · filed 2025-11-06 | ||||
| 2025-05-25 | $852.00K 10-Q · filed 2026-08-05 | $1.69M 10-Q · filed 2026-08-05 | $2.51M derived: sum of 3 quarters · filed 2026-08-05 | $3.32M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | $837.00K 10-Q · filed 2026-05-06 | $1.66M derived: sum of 2 quarters · filed 2026-05-06 | $2.47M 10-Q · filed 2025-04-03 | $3.26M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-11-24 | $822.00K 10-Q · filed 2025-01-02 | $1.63M derived: sum of 2 quarters · filed 2025-11-06 | $2.42M derived: sum of 3 quarters · filed 2026-03-16 | $3.19M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-08-25 | $806.00K 10-Q · filed 2025-11-06 | $1.60M derived: sum of 2 quarters · filed 2026-03-16 | $2.37M derived: sum of 3 quarters · filed 2026-03-16 | $3.14M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-05-26 | $791.00K derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16 | $1.57M derived: sum of 2 quarters · filed 2026-03-16 | $2.33M derived: sum of 3 quarters · filed 2026-03-16 | $3.08M 10-KT · filed 2026-03-16 | |
| 2024-02-25 | $776.00K 10-Q · filed 2025-04-03 | $1.54M derived: sum of 2 quarters · filed 2025-04-03 | $2.29M 10-Q · filed 2025-04-03 | ||
| 2023-11-26 | $763.00K 10-Q · filed 2025-01-02 | $1.51M derived: sum of 2 quarters · filed 2025-01-02 | |||
| 2023-08-27 | $748.00K 10-Q · filed 2025-01-02 | ||||
| 2023-05-28 | $1.16M 10-K · filed 2024-08-26 | ||||
| 2023-02-26 | $428.00K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |